Insiders · PBH

John E Byom

Director at Prestige Consumer Healthcare Inc. (PBH)

John E Byom has filed 8 insider reports with the SEC since August 2021, as director at Prestige Consumer Healthcare Inc. (PBH). In the last 12 months John E Byom sold $178K of stock on the open market. The latest filing, on August 5, 2026, reports grant or award at Prestige Consumer Healthcare Inc. (PBH).

Filings
8
Companies
1
Bought on market
None
Sold on market
$178K

Companies where John E Byom is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Prestige Consumer Healthcare Inc. logo
PBH
Prestige Consumer Healthcare Inc.
Director54,575$178K$48.00Aug 5, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare John E Byom with

Other insiders at the same companies

Questions about John E Byom

What is John E Byom's role at Prestige Consumer Healthcare Inc.?
John E Byom reports to the SEC as director at Prestige Consumer Healthcare Inc. (PBH), according to the latest filing on August 5, 2026.
How many shares does John E Byom own?
After the latest filing that states it, John E Byom directly owned 54,575 shares of Prestige Consumer Healthcare Inc. (PBH). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has John E Byom bought or sold stock recently?
The most recent open-market sale was on November 25, 2025: sold 3,000 shares of Prestige Consumer Healthcare Inc. (PBH) for $178K at an average of $59.35.
How do I get alerts when John E Byom files?
Follow John E Byom on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by John E Byom (SEC CIK 0001202329). Totals count each trade once, skipping amendments whose original is on file, from Aug 5, 2021 on. View on SEC EDGAR